MoneyWorks4Me

Cadila Healthcare informs about press release

29 May 2021 Evaluate

Cadila Healthcare has informed that it has enclosed a copy of press release dated May 29, 2021 titled ‘Zydus Cadila receives final approval from USFDA for Fluphenazine Hydrochloride Tablets’. Bring this news to the notice of the members of the exchange and the investors’ at large.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1745.00
Dr. Reddys Labs. 1242.00
Cipla 1331.00
Lupin 1953.75
Zydus Lifesciences 1113.00
View more..